Cargando…
Syndecan-2: Old Player in a New Field
Autores principales: | Obraztsova, Kseniya, Evans, Jilly, Krymskaya, Vera P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Thoracic Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6543750/ https://www.ncbi.nlm.nih.gov/pubmed/30896971 http://dx.doi.org/10.1165/rcmb.2019-0033ED |
Ejemplares similares
-
CrossTORC and WNTegration in Disease: Focus on Lymphangioleiomyomatosis
por: Evans, Jilly Frances, et al.
Publicado: (2021) -
Inhibition of Growth of TSC2-Null Cells by a PI3K/mTOR Inhibitor but Not by a Selective MNK1/2 Inhibitor
por: Evans, Jilly F., et al.
Publicado: (2019) -
Rapamycin-independent IGF2 expression in Tsc2-null mouse embryo fibroblasts and human lymphangioleiomyomatosis cells
por: Himes, Blanca E., et al.
Publicado: (2018) -
Lost in translation: a neglected mTOR target for lymphangioleiomyomatosis
por: Evans, Jilly F., et al.
Publicado: (2023) -
Metabolism and Cancer: Old and New Players
por: Cerella, Claudia, et al.
Publicado: (2013)